Hattersley; Gary

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hattersley; Gary.The latest application filed is for "uses of pthrp analogue in reducing fracture risk".

Company Profile

15.9.31

Hattersley; Gary - Stow MA
Hattersley; Gary - Stowe MA
Hattersley; Gary - Cambridge MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods for treating cancer Grant 11,413,258 - Hattersley August 16, 2	2022-08-16
USES OF PTHrP ANALOGUE IN REDUCING FRACTURE RISK App 20220125887 - Hattersley; Gary	2022-04-28
Methods For Treating Cancer App 20220110890 - HATTERSLEY; Gary	2022-04-14
Transdermal System For The Delivery Of Abaloparatide And Method Of Use For Treating Osteoporosis App 20210379162 - Brown; Kenneth ; et al.	2021-12-09
Formulations Of Abaloparatide, Transdermal Patches Thereof, And Uses Thereof App 20210369816 - Hattersley; Gary ; et al.	2021-12-02
Formulations of abaloparatide, transdermal patches thereof, and uses thereof Grant 10,980,862 - Hattersley , et al. April 20, 2	2021-04-20
METHOD OF DRUG DELIVERY FOR PTH, PTHrP AND RELATED PEPTIDES App 20210052705 - Hattersley; Gary ; et al.	2021-02-25
USES OF PTHrP ANALOGUE IN REDUCING FRACTURE RISK App 20200376088 - Hattersley; Gary	2020-12-03
Methods For Treating Cancer App 20200368183 - GARNER; Fiona ; et al.	2020-11-26
Zinc Compositions For Coated Microneedle Arrays App 20200306181 - Brown; Kenneth E. ; et al.	2020-10-01
Zinc compositions for coated microneedle arrays Grant 10,695,289 - Brown , et al.	2020-06-30
Ar+ Breast Cancer Treatment Methods App 20200171008 - Hattersley; Gary ; et al.	2020-06-04
Formulations Of Abaloparatide, Transdermal Patches Thereof, And Uses Thereof App 20200164045 - Hattersley; Gary ; et al.	2020-05-28
USES OF PTHrP ANALOGUE IN REDUCING FRACTURE RISK App 20200061160 - Hattersley; Gary	2020-02-27
Formulations of abaloparatide, transdermal patches thereof, and uses thereof Grant 10,568,937 - Hattersley , et al. Feb	2020-02-25
Methods For Treating Cancer App 20200046655 - Hattersley; Gary	2020-02-13
Methods For Treating Cancer App 20200038343 - Hattersley; Gary	2020-02-06
Methods For Treating Ovarian Cancer App 20200009085 - Hattersley; Gary	2020-01-09
METHOD OF DRUG DELIVERY FOR PTH, PTHrP AND RELATED PEPTIDES App 20190290738 - Hattersley; Gary ; et al.	2019-09-26
Formulations Of Abaloparatide, Transdermal Patches Thereof, And Uses Thereof App 20190117739 - HATTERSLEY; Gary ; et al.	2019-04-25
Formulations Of Pthrp Analogues, Transdermal Patches Thereof, And Uses Thereof App 20190091138 - HATTERSLEY; Gary ; et al.	2019-03-28
Zinc Compositions For Coated Microneedle Arrays App 20180289615 - BROWN; KENNETH E. ; et al.	2018-10-11
Methods For Treating Cancer App 20180214393 - HATTERSLEY; Gary	2018-08-02
Methods For Treating Cancer App 20180169101 - HATTERSLEY; Gary	2018-06-21
Methods For Treating Cancer App 20180153828 - GARNER; Fiona ; et al.	2018-06-07
USES OF A PTHrP ANALOGUE IN REDUCING FRACTURE RISK App 20170368148 - HATTERSLEY; Gary	2017-12-28
Ar+ Breast Cancer Treatment Methods App 20170368036 - HATTERSLEY; Gary ; et al.	2017-12-28
METHOD OF DRUG DELIVERY FOR PTH, PTHrP AND RELATED PEPTIDES App 20170189493 - HATTERSLEY; Gary ; et al.	2017-07-06
USES OF A PTHrP ANALOGUE IN REDUCING FRACTURE RISK App 20170065682 - HATTERSLEY; Gary	2017-03-09
Treatment of vasomotor symptoms with selective estrogen receptor modulators Grant 8,933,130 - Lyttle , et al. January 13, 2	2015-01-13
Method Of Drug Delivery For PTH, PTHrP And Related Peptides App 20140046293 - Hattersley; Gary ; et al.	2014-02-13
Method Of Drug Delivery For PTH, PTHrP And Related Peptides App 20140046292 - Hattersley; Gary ; et al.	2014-02-13
METHOD OF DRUG DELIVERY FOR PTH, PTHrP AND RELATED PEPTIDES App 20130006217 - Hattersley; Gary ; et al.	2013-01-03
Combination Therapy for BreastCancer Comprising an Antiestrogenic Agent App 20110124617 - Lyttle; C. Richard ; et al.	2011-05-26
Treatment of vasomotor symptoms with selective estrogen receptor modulators App 20100105733 - Lyttle; C. Richard ; et al.	2010-04-29
Human SDF-5 protein and compositions App 20060111562 - LaVallie; Edward R. ; et al.	2006-05-25
Human SDF-5 protein and compositions Grant 7,026,445 - LaVallie , et al. April 11, 2	2006-04-11
Cartilage induction by bone morphogenetic proteins Grant 5,902,785 - Hattersley , et al. May 11, 1	1999-05-11
Compositions comprising bone morphogenic proteins and truncated parathyroid hormone related peptide and methods of inducing cartilage by administration of same Grant 5,846,931 - Hattersley , et al. December 8, 1	1998-12-08

Company Registrations

SEC

0001521111

Hattersley Gary

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.